CVS Health's poor 2024 performance could be turning around in 2025 with a new CEO and potential rebound, despite challenges.

Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter ...

Shares of CVS Health Corp. CVS advanced 1.11% to $52.14 Wednesday, on what proved to be an all-around favorable trading ...

We recently published a list of 10 Hottest Large-Cap Stocks So Far in 2025. In this article, we are going to take a look at ...

We recently published a list of 10 Firms Dominate Monday Upsurge. In this article, we are going to take a look at where CVS ...

CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, February 12th, 2025, at 8:00 a.m. ET to discuss fourth quarter and full year 2024 financial results.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...

CVS Health Corp (CVS) stock saw a modest uptick, ending the day at $51.57 which represents a slight increase of $0.05 or 0.10% from the prior close of $51.52. The stock opened at $51.5 and touched a ...

CVS Health Corp (CVS) stock saw a modest uptick, ending the day at $48.01 which represents a slight increase of $2.00 or 4.35% from the prior close of $46.01. The stock opened at $46.44 and touched a ...

Shares of CVS Health Corp. CVS inched 0.10% higher to $51.57 Tuesday, on what proved to be an all-around positive trading ...